Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial
Hamed Kord‐Varkaneh, Ammar Salehi sahlabadi, Mihnea‐Alexandru Găman, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Fasting: From Physiology to Pathology
Dongmei Tang, Qiuyan Tang, Wei Huang, et al.
Advanced Science (2023) Vol. 10, Iss. 9
Open Access | Times Cited: 37
Intermittent fasting improves hepatic end points in nonalcoholic fatty liver disease: A systematic review and meta-analysis
Marcia Lange, Devika Nadkarni, Lily Martin, et al.
Hepatology Communications (2023) Vol. 7, Iss. 8
Open Access | Times Cited: 28
The Relationship between Pathogenesis and Possible Treatments for the MASLD-Cirrhosis Spectrum
Paulina Vidal‐Cevallos, Adriana P. Sorroza-Martínez, Norberto C. Chávez‐Tapia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4397-4397
Open Access | Times Cited: 8
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Children with Obesity: An Obesity Medicine Association (OMA) and Expert Joint Perspective 2025
Jennifer Panganiban, Mohit Kehar, Samar H. Ibrahim, et al.
Obesity Pillars (2025), pp. 100164-100164
Open Access | Times Cited: 1
Intermittent fasting—the future treatment in NASH patients?
Iulia Minciună, Suchira Gallage, Mathias Heikenwälder, et al.
Hepatology (2023) Vol. 78, Iss. 4, pp. 1290-1305
Closed Access | Times Cited: 18
Intermittent fasting regimens for metabolic dysfunction-associated steatotic liver disease: a systematic review and network meta-analysis of randomized controlled trials
Mohamed Abuelazm, Islam Mohamed, Ahmed Naeem, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 4, pp. 371-381
Closed Access | Times Cited: 7
Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease
Georg Semmler, Christian Datz, Michael Trauner
Clinical and Molecular Hepatology (2022) Vol. 29, Iss. Suppl, pp. S244-S260
Open Access | Times Cited: 23
Dietary strategies in non‐alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review
Alia Hadefi, Marianna Arvanitakis, Eric Trépo, et al.
United European Gastroenterology Journal (2023) Vol. 11, Iss. 7, pp. 663-689
Open Access | Times Cited: 14
Vitamin E supplementation in the treatment on nonalcoholic fatty liver disease (NAFLD): Evidence from an umbrella review of meta‐analysis on randomized controlled trials
Ming Yue Wang, Kousalya Prabahar, Mihnea‐Alexandru Găman, et al.
Journal of Digestive Diseases (2023) Vol. 24, Iss. 6-7, pp. 380-389
Closed Access | Times Cited: 14
Various types of fasting diet and possible benefits in nonalcoholic fatty liver: Mechanism of actions and literature update
Zahra Sadat Mirrazavi, Vahideh Behrouz
Clinical Nutrition (2024) Vol. 43, Iss. 2, pp. 519-533
Closed Access | Times Cited: 5
Intermittent Fasting: Myths, Fakes and Truth on This Dietary Regimen Approach
Simone Brogi, Rita Tabanelli, Sara Puca, et al.
Foods (2024) Vol. 13, Iss. 13, pp. 1960-1960
Open Access | Times Cited: 5
Efficacy of intermittent fasting on improving liver function in individuals with metabolic disorders: a systematic review and meta-analysis
Mousa Khalafi, Sara K. Rosenkranz, Faeghe Ghasemi, et al.
Nutrition & Metabolism (2025) Vol. 22, Iss. 1
Open Access
Effects of time restricted feeding combined with Lacto Ovo vegetarian diet on metabolic associated fatty liver disease management: a randomized clinical trial
Mahshad Shafiee, Amir Sadeghi, Fariba Taleghani, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Effect of the 5:2 Diet on Weight Loss and Cardiovascular Disease Risk Factors in Overweight and/or Obesity: A Systematic Review and Meta‐Analysis
Wu Cui, Binqin Chen, Jing Yu, et al.
International Journal of Endocrinology (2025) Vol. 2025, Iss. 1
Open Access
The efficacy of DASH combined with time-restricted feeding (16/8) on metabolic associated fatty liver disease management: a randomized controlled trial
Maryam Nilghaz, Amir Sadeghi, Glareh Koochakpoor, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The impacts of Ramadan fasting for patients with non-alcoholic fatty liver disease (NAFLD): a systematic review
Xiaoxiao Lin, Guomin Wu, Jinyu Huang
Frontiers in Nutrition (2024) Vol. 10
Open Access | Times Cited: 4
Effect of Intermittent Fasting on Lipid Profile, Anthropometric and Hepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A Systematic Review
María Fernanda Castillo, Daniela Salgado-Canales, Marco Arrese, et al.
Current Vascular Pharmacology (2024) Vol. 22, Iss. 3, pp. 187-202
Closed Access | Times Cited: 4
Effects of intermittent fasting combined with exercise on serum leptin and adiponectin in adults with or without obesity: a systematic review and meta-analysis of randomized clinical trials
Fatemeh Kazeminasab, Nasim Behzadnejad, Henrique Santa Capita Cerqueira, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 4
Beneficial effects of intermittent fasting on nonalcoholic fatty liver disease: a narrative review
Qingxuan Deng, Ruyue Lv, Haoqi Zou, et al.
Egyptian Liver Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Effects of intermittent fasting regimens on glycemic, hepatic, anthropometric, and clinical markers in patients with non-alcoholic fatty liver disease: Systematic review and meta-analysis of randomized controlled trials
Saleh A. K. Saleh, Heitor O. Santos, Mihnea‐Alexandru Găman, et al.
Clinical Nutrition ESPEN (2023) Vol. 59, pp. 70-80
Closed Access | Times Cited: 10
The effect of intermittent fasting on microbiota as a therapeutic approach in obesity
Santiago Cadena-Ullauri, Patricia Guevara-Ramírez, Viviana A Ruiz-Pozo, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 3
The effects of probiotic supplementation and exercise training on liver enzymes and cardiometabolic markers in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized clinical trials
Fatemeh Kazeminasab, Maryam Miraghajani, Khatereh Mokhtari, et al.
Nutrition & Metabolism (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Intermittent fasting and the liver: Focus on the Ramadan model
Mohamed Emara, Hanan Soliman, Ebada Said, et al.
World Journal of Hepatology (2024) Vol. 16, Iss. 8, pp. 1070-1083
Open Access | Times Cited: 3
Effect of 5:2 intermittent fasting diet versus daily calorie restriction eating on metabolic-associated fatty liver disease—a randomized controlled trial
Yuan-yuan Wang, Fang Tian, Xiaolu Qian, et al.
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 3
Ramadan fasting model exerts hepatoprotective, anti-obesity, and anti-hyperlipidemic effects in an experimentally-induced nonalcoholic fatty liver in rats
Abeer A. Alasmari, Abdulrahman Alkhalifah, Ahmed S. BaHammam, et al.
Saudi Journal of Gastroenterology (2023) Vol. 30, Iss. 1, pp. 53-62
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top